Dashboard
Manage Tickers

REVB REVELATION BIOSCIENCES, INC.


$ 1.38 $ 0.02 (1.49 %)    

Tuesday, 14-Oct-2025 17:34:43 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
$ 1.36
$ 1.38 x 5,746
$ 1.40 x 100
-- - --
$ 1.28 - $ 60.48
96,663
na
2.31M
$ 0.23
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/11/2025 17:06:18

revelation-biosciences-announces-immediate-exercise-of-436m-warrants-at-220share
Revelation Biosciences Announces Immediate...
09/11/2025 12:35:08

Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences comp...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
09/10/2025 12:11:03

revelation-biosciences-reports-gemini-significantly-reduced-inflammatory-activity-and-restored-normal-cellular-response-in-stage-3-and-4-ckd-patients
Revelation Biosciences Reports Gemini Sign...
09/10/2025 11:25:07

Gemini normalized the inflammatory response at the cellular level in stage 3 and 4 CKD patients.Gemini could potentially revolu...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
09/09/2025 21:06:08

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
09/09/2025 12:09:28

revelation-biosciences-announces-safety-and-activity-data-for-phase-1b-prime-study-gemini-normalized-the-inflammatory-response-at-the-cellular-level-in-stage-3-and-4-ckd-patients
Revelation Biosciences Announces Safety An...
09/09/2025 12:06:35

watching-revelation-bios-zacks-small-cap-research-gives-stock-2145-price-valuation
Watching Revelation Bios; Zacks Small-Cap ...
08/08/2025 16:07:11

https://s27.q4cdn.com/906368049/files/News/2025/Zacks_SCR_Research_08082025_REVB_Sorensen.pdf

revelation-biosciences-q2-eps-701-misses-149-estimate
Revelation Biosciences Q2 EPS $(7.01) Miss...
08/08/2025 10:43:02

Revelation Biosciences (NASDAQ:REVB) reported quarterly losses of $(7.01) per share which missed the analyst consensus estimate...

cder-director-tidmarsh-will-be-acting-head-of-fda-biologics-center-following-prasad-exit--endpoints-news
'CDER director Tidmarsh will be acting hea...
07/30/2025 16:28:20

https://endpoints.news/cder-director-tidmarsh-will-be-acting-head-of-fda-biologics-center-following-prasad-exit/

watching-revelation-biosciences-zacks-small-cap-research-gives-stock-2145share-valuation
Watching Revelation Biosciences; Zacks Sma...
07/09/2025 15:04:31

https://s27.q4cdn.com/906368049/files/News/2025/Zacks_SCR_Research_07092025_REVB_Sorensen.pdf

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
07/02/2025 12:06:54

us-stocks-likely-to-open-higher-sp-500-sees-average-gain-of-61-in-2nd-half-expert-says
US Stocks Likely To Open Higher: S&P 500 S...
07/02/2025 10:01:18

U.S. futures rose on Wednesday after a mixed close on Tuesday. Futures of major benchmark indices were trading slightly higher.

revelation-biosciences-reveals-1-for-3-reverse-stock-split-effective-july-7-2025
Revelation Biosciences Reveals 1-For-3 Rev...
07/01/2025 21:28:02

why-credo-technology-group-shares-are-trading-higher-by-over-14-here-are-20-stocks-moving-premarket
Why Credo Technology Group Shares Are Trad...
06/03/2025 10:30:29

crude-oil-falls-over-1-best-buy-reports-downbeat-results
Crude Oil Falls Over 1%; Best Buy Reports ...
05/29/2025 17:13:42

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
05/29/2025 17:07:05

nasdaq-gains-over-1-nvidia-posts-strong-revenue
Nasdaq Gains Over 1%; Nvidia Posts Strong ...
05/29/2025 13:55:20

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
05/29/2025 12:07:57

revelation-biosciences-announces-pricing-of-4m-public-offering-of-up-to-1456m-shares-at-an-offering-price-of-110shr
Revelation Biosciences Announces Pricing O...
05/29/2025 12:02:12

Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences comp...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION